Otto Metzger, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer (NCT02390427) | Otto Metzger, MD | 2015-04-20 |
Track Otto Metzger, MD automatically
Every clearance here is in the API, with alerts when new ones post.